Isha Abdullah

Isha Abdullah

Medical Directors at Concentra

In 1991 after completing her medical training at Aga Khan University , Isha moved to California where she completed her residency training in Internal Medicine at Kaiser Permanente Santa Clara followed by a fellowship in nephrology at Stanford University.

Isha joined The Cardiovascular Institute, a multidisciplinary group at El Camino Hospital.

In 2007, after a brief hiatus from clinical work, Isha returned to Stanford University to spearhead Clinical Trials at Stanford Nephrology/ Dermatology joint project. This paved the path for her to co-found bio technology company in 2010. Organ-i. was a molecular diagnostic company that developed a PCR based blood test, using patent protected genetic markers and a proprietary algorithm to detect acute rejection for renal transplant patients.

As President and CEO of Organ-i, Isha led all aspects of the company including, raising seed capital, business development, cultivating partnerships with external CLIA labs, initiating three prospective clinical trials and partnering with Bristol Myers Squibb. She stewarded the development of an outstanding scientific advisory board including Dr. Nancy Ascher chief of surgery at UCSF and Dr Henrik Ekberg, President of International Transplant Society.

Organ-i was acquired by Immucor, Inc. in 2014.

Isha has recently returned to clinical practice in 2017 and is currently one of the Medical Directors at Concentra.  

Isha has  served on several Boards at various Non-Profit Organizations including: First Graduate, a San Francisco based group with the mission to educate inner city children by tutoring, mentoring and making a financial commitment for 10 yrs to take them through high school and college, making them the first in their families to graduate from college; Unicef, The Lucille Packard Children’s Hospital Foundation, Advisory Board of the Dean of Stanford University and ING (Islamic Networks Group).